1-3 of 3
Karin Brændstrup
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Altered Splicing of RUNX1-RUNX1T1 in AML Impacts on Prognosis.

Hans Beier Ommen, Mette Oestergaard, Ming Yan, Karin Brændstrup, Dong-Er Zhang, Peter Hokland, M.D.
Journal: Blood
Blood (2008) 112 (11): 3352.
https://doi.org/10.1182/blood.V112.11.3352.3352
Published: 2008
Journal Articles

Relapse Prediction in AML Patients in Complete Remission Using WT1 as a Molecular Marker: Development of a Mathematical Model To Predict Time from Molecular to Clinical Relapse and Define Optimal Sampling Intervals.

Hans B. Ommen, MD, Charlotte G. Nyvold, PhD, Karin Brændstrup, Bodil L. Andersen, Ingrid B. Ommen, MSc, Henrik Hasle, PhD, Peter Hokland, DMSc, Mette Ostergaard, PhD
Journal: Blood
Blood (2007) 110 (11): 3495.
https://doi.org/10.1182/blood.V110.11.3495.3495
Published: 2007
Journal Articles

Evidence for T-Cell Involvement in MDS: Similar Patterns of Hypermethylation of Key Genes in Purified CD34+ and CD3+ Cell Fractions in an RAEB Patient.

Anni Aggerholm, PhD, Anita Rethmeier, PhD, Per Guldberg, PhD, Ingrid Carlsen, MedTech, Karin Brændstrup, MedTech, Peter Hokland, MD, DMedSci
Journal: Blood
Blood (2004) 104 (11): 4712.
https://doi.org/10.1182/blood.V104.11.4712.4712
Published: 2004